UNSPSC 85892670: High dose rate (hdr) brachytherapy of mediastinum using iridium 192 (ir-192)

This classification denotes the group of activities that yields a radiation therapy intervention or procedure of high dose rate (hdr) brachytherapy of mediastinum using iridium 192 (ir-192). This intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code DB1698Z

UNSPSC 85892670 High dose rate brachytherapy of mediastinum using iridium 192 (IR-192) is a Commodity code that nominally describes a specialized oncology radiation therapy procedure, yet the single recent state and local opportunity posted under this code shows no alignment with that clinical scope. The Santa Clara County Health System's July 2026 solicitation (RFSQHHSFY270052) for temporary health professional staffing services establishes a qualified vendor pool across thirteen ancillary clinical categories — Audiology, Cardiology and Vascular, Diagnostic Imaging/Radiology, Gastroenterology, Health Services Assistant, Medical Social Worker, Ophthalmology, Orthopedic, Patient Transporter, Respiratory Care, Sterile Processing, Surgical/Operating Room/Labor and Delivery, and Therapy Services — with no reference to brachytherapy, oncology, or radiation therapy personnel. The mismatch signals either a coding error in the Santa Clara Health System's procurement tagging or a drift between the UNSPSC code's nominal scope and actual procurement use in state and local health-system contracting.

The code shows minimal recent activity. The Santa Clara Health System opportunity, due October 7, 2026, is structured as a non-exclusive, multiple-award qualification vehicle with no guaranteed work volume; the Health System may maintain the qualified list for five years and contract with selected vendors as operational needs arise. Proposers may bid on all categories or specialize in single ancillary disciplines without penalty. With only one recent opportunity visible and its scope plainly misaligned with the code's brachytherapy focus, the code does not appear to be actively used for state and local procurement of specialized oncology radiation therapy services or related staffing at this time.